Servier’s brain tumour treatment approved by US FDA
Servier Pharmaceuticals said the US FDA approved its treatment for a type of brain tumour, becoming the first drug to gain approval in the US for the disease. The drug, known as voranigo, is used to treat a form of brain cancer, called IDH-mutated grade 2 glioma, in patients who have undergone surgery.
ПОПУЛЯРНЫЕ ПОСТЫ
Portugal declares risk as wildfires hit the north of the country
Сентябрь 17, 2024
UK to appoint nature envoy
Сентябрь 17, 2024
Death tolls rises as Central Europe floods
Сентябрь 17, 2024
ПОДПИСЫВАЙТЕСЬ НА НАС
ПРЯМАЯ ТРАНСЛЯЦИЯ